Gotham Makker

Insider Reports History

Location
430 East 29 Th Street, Suite 1040, New York, NY
Signature
/s/ Martin Wilson, as attorney-in-fact for Gotham Makker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gotham Makker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Director Common Stock 622K $4.88M $7.86 Jun 18, 2025 By Non-Revocable Trust
ROCKET PHARMACEUTICALS, INC. Director Common Stock 415K $3.26M $7.86 Jun 18, 2025 By Simran Investment Group
ROCKET PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 303 $4.56K $15.04 Sep 26, 2024 Direct

Insider Reports Filed by Gotham Makker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Jun 18, 2025 2 $0 4 Jul 18, 2025 Director
RCKT ROCKET PHARMACEUTICALS, INC. Sep 26, 2024 2 $0 4 Oct 29, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2024 2 $40K 4 Jun 20, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Mar 21, 2024 1 -$7.79M 4/A Jun 10, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Mar 21, 2024 1 -$7.79M 4 Mar 25, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Nov 15, 2023 1 -$451K 4 Nov 16, 2023 Director
RCKT ROCKET PHARMACEUTICALS, INC. Sep 28, 2023 2 -$316K 4 Oct 2, 2023 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 22, 2023 2 $40K 4 Jun 26, 2023 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2022 2 $40K 4 Jun 15, 2022 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jul 27, 2021 1 $0 4 Mar 9, 2022 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 16, 2021 2 -$1.64M 4 Jun 21, 2021 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 14, 2021 2 $45K 4 Jun 16, 2021 Director